AREV Life Sciences Global Corp. announced the appointment of Sateesh Apte MD to the Scientific Advisory Board (the SAB) of AREV. AREV Life Sciences announced the appointment of Sateesh Apte MD to its Scientific Advisory Board, as part of the current scale up for launching clinical studies of SUSTAINNTM for treating Serious Acute Malnutrition in Low & Middle Income Countries.

"LMIC". Dr Apte"s expertise in neurological pathogenesis will complement AREV's focus on positioning SUSTAINNTM to address the cognitive preservation of children experiencing serious acute malnutrition, which causes brain damage in millions of malnourished children a year. Said Mike Withrow, CEO of AREV Life Sciences Dr. Apte's appointment to the SAB of AREV is a critical step in successfully designing studies to demonstrate the clinical value of SUSTAINN in treating SAM.

Dr. Apte specializes in neurology and has an extensive background in research, teaching and consulting in the field of neurological sciences. Dr. Apte"s graduate training was at Haffkine Institute in Mumbai, India, The Pasteur Institute in Paris, France, at Harvard Medical School in Boston and at Stanford University in California. His professional appointments have included active staff positions at the VA Medical Center and Valley Memorial Hospital in Livermore, CA; ValleyCare Medical Center in Pleasanton, CA, and directorships with PainCare Medical Clinic, and the Sleep Disorders Center in San Ramon and Pleasanton, CA.

He most recently served as President and CEO of Northern California Physicians Associates Inc. and Alpha Medical Group Inc. (1986-1992) He served as President and CEO of ImmunoScience Inc. in Pleasanton, CA until 2019. Dr. Apte has authored and co-authored a number of articles for medical journals and has several publications pending.